JPMorgan Chase Declares Quarterly Dividend of 150 Per Share Trump Administration Proposes GovernmentWide NonDisclosure Agreements for Federal Employees Lockheed Martin Stock Gains as USIran Tensions Escalate Micron Technology Surpasses 1 Trillion Market Cap Following UBS Price Target Upgrade HPCL Options Strategy Long Strangle Positioned for Potential ShortTerm Volatility Marvell Technology Stock Declines Despite AIDriven Revenue Growth Accelerating CYD Q3 2020 Earnings NearMiss on EPS Stock Gains Despite Slight Disappointment Mount Logan Capital Inc Q1 2026 Earnings Loss Per Share of 051 Amidst Market Headwinds NVMI Q1 2026 Earnings Solid EPS Beat Lifts Shares Amid Steady Demand DuPont de Nemours Inc DD Q1 2026 Earnings EPS Surpasses Expectations by Double Digits AARD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress HUN Q1 2026 Earnings Narrower Loss Beats Estimates Stock Rises 425 JAKKS Pacific JAKK Edges Higher as Stock Hovers Near Resistance Aebi Schmidt Holding AG AEBI Edges Higher as Shares Climb Over 2 Key Levels in Focus Coincheck Group CNCK Rallies 2 as Crypto Sentiment Shows Signs of Recovery Approaches Key Resistance Axe Compute Inc AGPU Sinks 6 as Selling Pressure Intensifies Testing Key Support Near 507 Pulse Biosciences PLSE Holds Steady Key Levels in Focus Traders Now Price Fed Rate Hike as Next Move Following Inflation Surge OSRH Q4 2025 Earnings EPS Miss of 569 Triggers Stock Decline Invesco Municipal Trust VKQ Edges Higher as Bond Market Stabilizes AEE Q1 2026 Earnings EPS Beats Estimates as Utility Gains on Operational Efficiency LPLA Q1 2026 Earnings Marginal EPS Beat Meets a Cautious Market MAMA Q1 2026 Earnings Strong EPS Beat Amid Revenue Ambiguity and Stock Dip SWKHL Q3 2025 Earnings Strong EPS Beat of 70 Delivers 59 Cents Per Share Helix Energy Solutions Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher NovaBridge Biosciences NBP Q4 2025 Earnings Staggering EPS Miss as PreRevenue Biotech Faces Development Headwinds CVKD Q1 2026 Earnings NarrowerthanExpected Loss as PreRevenue Biotech Advances Pipeline